Espen Ajo Arnevik
Overview
Explore the profile of Espen Ajo Arnevik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ellefsen R, De Pirro S, Haukland V, Wusthoff L, Arnevik E
Harm Reduct J
. 2024 Dec;
21(1):230.
PMID: 39741328
Background: Little attention has been paid to the experiences of clinicians and health personnel who provide heroin-assisted treatment (HAT). This study provides the first empirical findings about the clinicians' experiences...
2.
Johannessen D, Overa S, Arnevik E
Front Psychol
. 2024 Feb;
15:1247152.
PMID: 38410405
Introduction: Recovery from complex conditions such as gambling disorders (GD) often entail considerable change and require a range of adaptable interventions in the health care system. Outcomes from such avenues...
3.
Ellefsen R, Wusthoff L, Arnevik E
Harm Reduct J
. 2023 Jun;
20(1):73.
PMID: 37312181
Background: Heroin-assisted treatment (HAT) involves supervised dispensing of medical heroin (diacetylmorphine) for people with opioid use disorder. Clinical evidence has demonstrated the effectiveness of HAT, but little is known about...
4.
Rognli E, Stome L, Kvaerner K, Wilhelmsen C, Arnevik E
Nordisk Alkohol Nark
. 2023 Apr;
40(2):199-211.
PMID: 37063816
Unemployment rates for individuals in treatment for substance use disorder (SUD) are high, with Norwegian estimates in the range of 81%-89%. Although Individual Placement and Support (IPS) represents a promising...
5.
Rognli E, Dalsrud M, Wusthoff L, Arnevik E
Tidsskr Nor Laegeforen
. 2023 Mar;
143(5).
PMID: 36987889
Background: The patient pathway for follow-up after a drug overdose, which is an important part of Norway's national overdose strategy, started up on 1 January 2022. Four years earlier, a...
6.
Naess O, Ekeland T, Arnevik E, Aarstad J, Lid T
Eval Program Plann
. 2023 Mar;
98:102271.
PMID: 36921405
Norwegian health services have undergone marked logistical changes in organization and funding over recent decades. One significant change was the new public management-inspired commissioner's document, first issued in 2013 by...
7.
Baekkelund H, Ulvenes P, Boon-Langelaan S, Arnevik E
BMC Psychiatry
. 2022 May;
22(1):338.
PMID: 35578194
Background: Patients with complex dissociative disorders (CDD) report high levels of childhood- abuse experiences, clinical comorbidity, functional impairment, and treatment utilization. Although a few naturalistic studies indicate that these patients...
8.
Rognli E, Aas E, Drake R, Marsden J, Anders P, Bond G, et al.
Trials
. 2021 Oct;
22(1):705.
PMID: 34654464
Background: Employment is associated with better outcomes of substance use treatment and protects against relapse after treatment completion. Unemployment rates are high for people with substance use disorders (SUD) who...
9.
Hartveit Kvarstein E, Zahl K, Stanicke L, Pettersen M, Baltzersen A, Johansen M, et al.
Nord J Psychiatry
. 2021 Aug;
:1-12.
PMID: 34369842
Background: Relational and emotional problems, dysregulation, self-harming or substance abuse often characterize personality disorders (PD). In Norway, COVID-19 restrictions led to an abrupt shutdown of services from 12 March 2020...
10.
Hartveit Kvarstein E, Zahl K, Stanicke L, Pettersen M, Baltzersen A, Johansen M, et al.
Nord J Psychiatry
. 2021 Jun;
76(1):52-63.
PMID: 34126854
Background: The societal shutdown due to the Covid-19 pandemic involved mental health services for personality disorder (PD) and was introduced from 12 March 2020 in Norway. Rapid implementation of treatment...